Search results for “Idiopathic thrombocytopenia” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 69 patents, we discovered top 29 key players by total patent application. Amgen, Inc., MacroGenics, Inc., Laboratoire Francais du Fractionnement et des Biotechnologies S.A. are dominant in this area. They take 43.48% of the total patent filing.
California, United States
Patent: 14
United States
Patent: 8
Hamburg, Germany
Patent: 3
Spain
Patent: 3
Maharashtra, India
Patent: 3
Belgium
Patent: 3
Massachusetts, United States
Patent: 2
Massachusetts, United States
Patent: 2
Canada
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents applied in the last 5 years. We discover 12 most active companies in this area. The fast-growing Amgen, Inc., Alfred E. Tiefenbacher (GmbH & Co. KG), UCB Biopharma SRL take 57.14% of patent filing during this period.
California, United States
Patent: 6
Hamburg, Germany
Patent: 3
Belgium
Patent: 3
Spain
Patent: 3
France
Patent: 1
Jilin Sheng, China
Patent: 1
New York, United States
Patent: 1
Centre National De La Recherche Scientif
France
Patent: 1
France
Patent: 1
undefined undefined
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 21 patents in last 5 years, we discover 11 new entrants. Alfred E. Tiefenbacher (GmbH & Co. KG), UCB Biopharma SRL, UCB Pharma SA are the most active new entrants in this area.
Hamburg, Germany
Patent: 3
Belgium
Patent: 3
Spain
Patent: 3
France
Patent: 1
Jilin Sheng, China
Patent: 1
New York, United States
Patent: 1
Centre National De La Recherche Scientif
France
Patent: 1
France
Patent: 1
undefined undefined
Patent: 1
China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 10 patents, we discovered top 4 universities and scientific research institutions by total patent application. Liverpool School of Tropical Medicine, Jilin University, Guizhou Normal University are dominant in this area. They take 60.00% of the total patent filing.
CITY OF LIVERPOOL, United Kingdom
Patent: 2
Jilin Sheng, China
Patent: 1
Guizhou Sheng, China
Patent: 1
Jiangsu Sheng, China
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: